iRadimed Corp (IRMD) USD0.0001

Sell:$20.97Buy:$56.71$1.40 (2.65%)

Prices delayed by at least 15 minutes
Sell:$20.97
Buy:$56.71
Change:$1.40 (2.65%)
Prices delayed by at least 15 minutes
Sell:$20.97
Buy:$56.71
Change:$1.40 (2.65%)
Prices delayed by at least 15 minutes

Company Information

About this company

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.

Key people

Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
John F. Glenn
Chief Financial Officer, Corporate Secretary
Randy Waddell
Vice President - Worldwide Sales and Marketing
James B. Hawkins
Director
Monty K. Allen
Independent Director
Hilda Scharen-guivel
Independent Director
Anthony Vuoto
Independent Director

Key facts

  • EPIC
    IRMD
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US46266A1097
  • Market cap
    $665.13m
  • Employees
    160
  • Shares in issue
    12.72m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.